Culanag, Rowena C.

HRN: 00-96-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
CEFUROXIME 1.5GM (VIAL)
08/07/2025
08/13/2025
IV
1.5
Q8
Lacerated Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines